Handling uncertainty using features from pathology: opportunities in
primary care data for developing high risk cancer survival methods
- URL: http://arxiv.org/abs/2012.09976v1
- Date: Thu, 17 Dec 2020 23:27:13 GMT
- Title: Handling uncertainty using features from pathology: opportunities in
primary care data for developing high risk cancer survival methods
- Authors: Goce Ristanoski, Jon Emery, Javiera Martinez-Gutierrez, Damien
Mccarthy, Uwe Aickelin
- Abstract summary: More than 144 000 Australians were diagnosed with cancer in 2019.
The majority will first present to their GP symptomatically, even for cancer for which screening programs exist.
We investigate how past pathology test results can lead to deriving features that can be used to predict cancer outcomes.
- Score: 0.10499611180329804
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: More than 144 000 Australians were diagnosed with cancer in 2019. The
majority will first present to their GP symptomatically, even for cancer for
which screening programs exist. Diagnosing cancer in primary care is
challenging due to the non-specific nature of cancer symptoms and its low
prevalence. Understanding the epidemiology of cancer symptoms and patterns of
presentation in patient's medical history from primary care data could be
important to improve earlier detection and cancer outcomes. As past medical
data about a patient can be incomplete, irregular or missing, this creates
additional challenges when attempting to use the patient's history for any new
diagnosis. Our research aims to investigate the opportunities in a patient's
pathology history available to a GP, initially focused on the results within
the frequently ordered full blood count to determine relevance to a future
high-risk cancer prognosis, and treatment outcome. We investigated how past
pathology test results can lead to deriving features that can be used to
predict cancer outcomes, with emphasis on patients at risk of not surviving the
cancer within 2-year period. This initial work focuses on patients with lung
cancer, although the methodology can be applied to other types of cancer and
other data within the medical record. Our findings indicate that even in cases
of incomplete or obscure patient history, hematological measures can be useful
in generating features relevant for predicting cancer risk and survival. The
results strongly indicate to add the use of pathology test data for potential
high-risk cancer diagnosis, and the utilize additional pathology metrics or
other primary care datasets even more for similar purposes.
Related papers
- Application analysis of ai technology combined with spiral CT scanning
in early lung cancer screening [15.6839495538166]
The overall 5-year survival rate of lung cancer patients is still lower than 20% and is staged.
In recent years, artificial intelligence technology has gradually begun to be applied in oncology.
This study applied the combined method in early lung cancer screening, aiming to find a safe and efficient screening mode.
arXiv Detail & Related papers (2024-01-26T07:58:09Z) - Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep
Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023.
The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy.
In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
arXiv Detail & Related papers (2023-04-12T15:08:34Z) - A Multi-Institutional Open-Source Benchmark Dataset for Breast Cancer
Clinical Decision Support using Synthetic Correlated Diffusion Imaging Data [82.74877848011798]
Cancer-Net BCa is a multi-institutional open-source benchmark dataset of volumetric CDI$s$ imaging data of breast cancer patients.
Cancer-Net BCa is publicly available as a part of a global open-source initiative dedicated to accelerating advancement in machine learning to aid clinicians in the fight against cancer.
arXiv Detail & Related papers (2023-04-12T05:41:44Z) - Artificial intelligence based prediction on lung cancer risk factors
using deep learning [0.0]
Capturing and defining symptoms at an early stage is one of the most difficult phases for patients.
We developed a model that can detect lung cancer with a remarkably high level of accuracy using the deep learning approach.
We found that our model achieved an accuracy of 94% and a minimum loss of 0.1%.
arXiv Detail & Related papers (2023-04-11T08:57:15Z) - Deep Learning Approach for Early Stage Lung Cancer Detection [0.0]
The survival rate for lung cancer patients is very low compared to other cancer patients due to late diagnostics.
This paper proposed a deep-learning model for early lung cancer prediction and diagnosis from Computed Tomography (CT) scans.
arXiv Detail & Related papers (2023-02-05T18:50:12Z) - Deep learning methods for drug response prediction in cancer:
predominant and emerging trends [50.281853616905416]
Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans.
A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods.
This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
arXiv Detail & Related papers (2022-11-18T03:26:31Z) - Enhancing Clinical Support for Breast Cancer with Deep Learning Models
using Synthetic Correlated Diffusion Imaging [66.63200823918429]
We investigate enhancing clinical support for breast cancer with deep learning models.
We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort.
We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
arXiv Detail & Related papers (2022-11-10T03:02:12Z) - Machine Learning-based Lung and Colon Cancer Detection using Deep
Feature Extraction and Ensemble Learning [0.9786690381850355]
We introduce a hybrid ensemble feature extraction model to efficiently identify lung and colon cancer.
It integrates deep feature extraction and ensemble learning with high-performance filtering for cancer image datasets.
Our model can detect lung, colon, and (lung and colon) cancer with accuracy rates of 99.05%, 100%, and 99.30%, respectively.
arXiv Detail & Related papers (2022-06-02T15:14:41Z) - Intelligent Sight and Sound: A Chronic Cancer Pain Dataset [74.77784420691937]
This paper introduces the first chronic cancer pain dataset, collected as part of the Intelligent Sight and Sound (ISS) clinical trial.
The data collected to date consists of 29 patients, 509 smartphone videos, 189,999 frames, and self-reported affective and activity pain scores.
Using static images and multi-modal data to predict self-reported pain levels, early models show significant gaps between current methods available to predict pain.
arXiv Detail & Related papers (2022-04-07T22:14:37Z) - Early Diagnosis of Lung Cancer Using Computer Aided Detection via Lung
Segmentation Approach [0.1749935196721634]
American Cancer Society estimates about 27% of the deaths because of cancer.
In the early phase of its evolution, lung cancer does not cause any symptoms usually.
Many of the patients have been diagnosed in a developed phase where symptoms become more prominent, that results in poor curative treatment and high mortality rate.
arXiv Detail & Related papers (2021-07-23T05:46:06Z) - Topological Data Analysis of copy number alterations in cancer [70.85487611525896]
We explore the potential to capture information contained in cancer genomic information using a novel topology-based approach.
We find that this technique has the potential to extract meaningful low-dimensional representations in cancer somatic genetic data.
arXiv Detail & Related papers (2020-11-22T17:31:23Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.